Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg. Results from a placebo-controlled study in children younger than 12 years with acute gastroenteritis did not show any difference in efficacy at relieving nausea and vomiting compared with placebo.
Enforcement Report - Week of February 6, 2019
Duran's Health Pharmacy receives FDA Form 483
The national drug pricing regulator NPPA has fixed the retail and ceiling prices of 22 formulations used for treatment of various ailments including HIV, bacterial infections and cardiac conditions among others.
Trone Health Services, Inc. dba Medicap Pharmacy Receives FDA Warning Letter
Athena DDS Pvt. Ltd, specialized for the development of Solid Orals, announces the launch ofnDomperidone OD
Enforcement Report - Week of March 8, 2017
This study investigates the extrusion-spheronization performance of some mixtures of co-processed ?-carrageenan and pectin (as excipient), and sodium starch glycolate (as superdisintegrant). Attention is focused with an objective to improve the mechanical stability and the dissolution rate of poorly-soluble domperidone (as a model drug). Initially co-processed ?-carrageenan- pectin excipient is prepared with different ratios of ?-carrageenan and pectin. Different marketed brands of ?-carrageenan (Gelcarin, Aquagel, and Eugel) were employed and dried by solvent evaporation method. Further characterization was carried out by SEM, XRD and FTIR analysis. Pellets were prepared using extrusion-spheronization technique. Pellets were evaluated for flow properties, particle size, sphericity, tensile strength, friability, disintegration time, and in-vitro drug release studies.
Freedom Pharma recalls Domperidone BP due to Penicillin Cross Contamination
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.